Total Payments
$329.25
2024 Payments
$142.43
Companies
7
Transactions
13
Medicare Patients
829
Medicare Billing
$75,731
Payment Breakdown by Category
Food & Beverage$329.25 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $329.25 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Women's Health, Inc. | $108.57 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $88.84 | 5 | $0 (2024) |
| PFIZER INC. | $51.82 | 3 | $0 (2024) |
| Lilly USA, LLC | $25.60 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $20.98 | 1 | $0 (2024) |
| Abbott Laboratories | $17.19 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $16.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.43 | 7 | GlaxoSmithKline, LLC. ($43.19) |
| 2023 | $157.26 | 4 | Myriad Women's Health, Inc. ($108.57) |
| 2022 | $13.31 | 1 | GlaxoSmithKline, LLC. ($13.31) |
| 2019 | $16.25 | 1 | Merck Sharp & Dohme Corporation ($16.25) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BEXSERO | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Biological | ||||||
| 09/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes Care | ||||||
| 04/22/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: VACCINES | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $108.57 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINES | ||||||
| 05/08/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: VACCINES | ||||||
| 11/01/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: VACCINES | ||||||
| 03/18/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 226 | 337 | $36,235 | $21,537 |
| 2022 | 5 | 250 | 385 | $38,569 | $23,316 |
| 2021 | 5 | 219 | 318 | $34,516 | $21,012 |
| 2020 | 5 | 134 | 201 | $22,836 | $9,867 |
Total Patients
829
Total Services
1,241
Medicare Billing
$75,731
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 180 | $17,704 | $10,596 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 46 | 59 | $8,656 | $5,717 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 40 | 54 | $3,810 | $2,630 | 69.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 44 | $6,065 | $2,594 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 113 | 202 | $19,242 | $11,822 | 61.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 69 | 92 | $12,423 | $7,677 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 33 | 51 | $3,207 | $2,199 | 68.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 23 | $2,507 | $1,287 | 51.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 14 | 17 | $1,190 | $330.24 | 27.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 74 | 116 | $15,842 | $10,636 | 67.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 78 | 117 | $11,666 | $7,235 | 62.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 25 | $2,991 | $1,307 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 31 | $1,987 | $1,115 | 56.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 27 | 29 | $2,030 | $717.92 | 35.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 81 | 133 | $12,746 | $6,370 | 50.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 20 | $2,180 | $1,093 | 50.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 12 | 13 | $1,729 | $1,070 | 61.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 15 | $4,961 | $813.29 | 16.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 20 | $1,220 | $521.07 | 42.7% |
About Dr. Jennifer Shonk, DO
Dr. Jennifer Shonk, DO is a Family Medicine healthcare provider based in Pullman, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1700236833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Shonk, DO has received a total of $329.25 in payments from pharmaceutical and medical device companies, with $142.43 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($329.25).
As a Medicare-enrolled provider, Shonk has provided services to 829 Medicare beneficiaries, totaling 1,241 services with total Medicare billing of $75,731. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pullman, WA
- Active Since 06/20/2016
- Last Updated 08/04/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700236833
Products in Payments
- MYRISK (Device) $108.57
- SHINGRIX (Biological) $38.68
- AREXVY (Drug) $36.85
- PAXLOVID (Drug) $35.47
- MOUNJARO (Drug) $25.60
- Veozah (Drug) $20.98
- FREESTYLE LIBRE 3 (Device) $17.19
- TRUMENBA (Biological) $16.35
- NEXPLANON (Drug) $16.25
- BEXSERO (Biological) $13.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pullman
Stephen Hall, M.d, M.D
Family Medicine — Payments: $2,118
Family Medicine $2,118
Brenna Harris, D.o, D.O
Family Medicine — Payments: $755.79
Family Medicine $755.79
Dr. Angila Jaeggli, N.d, N.D
Family Medicine — Payments: $144.06
Family Medicine $144.06
Deborah Collins, Md, MD
Family Medicine — Payments: $106.64
Family Medicine $106.64
Kassandra Tricola, M.d, M.D
Family Medicine — Payments: $104.05
Family Medicine $104.05
Christopher Iacobelli, Md, MD
Family Medicine — Payments: $58.94
Family Medicine $58.94